Marco Cavaleri
Overview
Explore the profile of Marco Cavaleri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
3524
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Buoninfante A, Andeweg A, Genov G, Cavaleri M
NPJ Vaccines
. 2024 Jun;
9(1):122.
PMID: 38942751
Following the start of the COVID-19 vaccination campaign, the adverse events of myocarditis and pericarditis were linked mainly to mRNA COVID-19 vaccines by the regulatory authorities worldwide. COVID-19 vaccines have...
2.
La Via L, Cavaleri M, Terminella A, Sorbello M, Cusumano G
J Clin Med
. 2024 Jun;
13(11).
PMID: 38892852
Robotic thoracic surgery is a prominent minimally invasive approach for the treatment of various thoracic diseases. While this technique offers numerous benefits including reduced blood loss, shorter hospital stays, and...
3.
Robotic surgery for thymic cysts: clinical features, management, and results of a multicentric study
Cusumano G, Meacci E, Romano G, Cavaleri M, Congedo M, Davini F, et al.
Updates Surg
. 2024 May;
PMID: 38816604
Thymic cysts are rare, radiological diagnosis is often incidental, and cysts seldom assume clinical relevance for symptoms of compression. Thymoma were occasionally found inside both complex and simple thymic cysts....
4.
Buchholz S, Di Meco E, Balkowiec-Iskra E, Sepodes B, Cavaleri M
Nat Med
. 2024 May;
30(8):2109-2110.
PMID: 38806678
No abstract available.
5.
Cavaleri M, Kaslow D, Boateng E, Chen W, Chiu C, Choy R, et al.
Biologicals
. 2024 Feb;
85:101745.
PMID: 38341355
Many aspects of Controlled Human Infection Models (CHIMs, also known as human challenge studies and human infection studies) have been discussed extensively, including Good Manufacturing Practice (GMP) production of the...
6.
Giersing B, Isbrucker R, Kaslow D, Cavaleri M, Baylor N, Maiga D, et al.
Lancet Glob Health
. 2023 Oct;
11(11):e1819-e1826.
PMID: 37858591
Shigellosis causes considerable public health burden, leading to excess deaths as well as acute and chronic consequences, particularly among children living in low-income and middle-income countries (LMICs). Several Shigella vaccine...
7.
Schonborn L, Seck S, Thiele T, Kaderali L, Hoffmann T, Hlinka A, et al.
J Thromb Haemost
. 2023 Jul;
21(9):2519-2527.
PMID: 37394120
Background: Rapid diagnosis and treatment has improved outcome of patients with vaccine-induced immune thrombocytopenia and thrombosis (VITT). However, after the acute episode, many questions on long-term management of VITT remained...
8.
Asturias E, Excler J, Ackland J, Cavaleri M, Fulurija A, Long R, et al.
Clin Infect Dis
. 2023 May;
77(6):917-924.
PMID: 37232372
Streptococcus pyogenes (Strep A) infections result in a vastly underestimated burden of acute and chronic disease globally. The Strep A Vaccine Global Consortium's (SAVAC's) mission is to accelerate the development...
9.
Buoninfante A, Andeweg A, Baker A, Borad M, Crawford N, Dogne J, et al.
NPJ Vaccines
. 2022 Nov;
7(1):141.
PMID: 36351906
No abstract available.
10.
de Vries S, Starokozhko V, Schellens I, Wijnans L, Enzmann H, Cavaleri M, et al.
BMJ Glob Health
. 2022 Mar;
7(3).
PMID: 35304352
An under-representation of women and a lack of sex-specific analyses in COVID-19 trials has been suggested. However, the higher number of men than women who are severely affected by COVID-19...